Aaaaaaaaand it's finally out! Check out our latest publication in Science Translational Medicine - out today!
Disrupting the platelet internal membrane via PI3KC2α inhibition impairs thrombosis independently of canonical platelet activation.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Jul 2020All 27 dated mentions so far are from Jul 2020.
Where it's discussed
-
X / Twitter25 posts
-
News14 articles
-
YouTube2 videos
-
Facebook2 posts
AI synopsis
What people are saying
The discussions frequently praise the study's innovative approach to preventing dangerous blood clots without increasing bleeding risk, using enthusiastic language like 'breaking' and 'super important,' and referencing potential clinical benefits, which reflects both high interest and belief in the significance of the findings.
Most discussions express strong support for the significance and novelty of the findings, emphasizing the importance of the new approach for preventing thrombosis without impairing normal clotting.
Posts demonstrate high interest, highlighting the potential impact on cardiovascular treatment and discussing mechanisms involved, indicating engagement with the research's implications.
Discussions include references to the research methods, the potential for safer medications, and reactions like 'breaking' and 'super important,' showing deep engagement with the topic.
User comments suggest the research could be a breakthrough, with mentions of 'game-changing' potential and the promise of safer therapies, underlining the high perceived impact.
Abstract in brief
- The study explores a new way to prevent blood clots (thrombosis) without increasing bleeding risk by targeting a specific enzyme, PI3KC2, in platelets.
- Inhibiting PI3KC2 enlarges platelet internal membranes but does not impair normal platelet functions like blood clotting during injury, yet it significantly reduces the formation of dangerous arterial clots in both laboratory and animal tests.
- The anti-clotting effect is due to impaired platelet adhesion under high shear stress, suggesting that drugs targeting platelet internal membranes could offer safer and more effective treatments for preventing heart attacks and strokes.]
Top posts
Most liked on X and BlueskyDisrupting the platelet internal membrane via PI3KC2α inhibition impairs thrombosis independently of canonical platelet activation https://t.co/6gQqPZofCw
Really cool work from Justin @lab_hamilton!! Disrupting the platelet internal membrane via PI3KC2α inhibition impairs thrombosis independently of canonical platelet activation | Science Translational Medicine https://t.co/2oGaLyGugX
Disrupting the platelet internal membrane via PI3KC2α inhibition impairs thrombosis independently of canonical platelet activation https://t.co/uuEE6UXDBq
Breaking!!! Super duper important! Read please if you are a CV specialist : Disrupting the platelet internal membrane via PI3KC2α inhibition impairs thrombosis independently of canonical platelet activation | Science Translational Medicine https://t.co/6NAUCHBXjn
@lab_hamilton @MonashUni research in @ScienceTM proposes novel compound to prevent pathogenic blood clots but not interfere w normal clotting, unlike current #Heart_attack & #stroke medications DOI:10.1126/scitranslmed.aar8430. A/Prof Hamilton explains: https://t.co/dGbYQdyTmQ https://t.co/avgTPTQ7Ra
All mentions
Targeting Platelet Internal Membranes to Prevent Thrombosis in COVID-19
Associate Professor Justin Hamilton's recent research focuses on a compound targeting pathogenic clots. This innovative approach offers potential for safer thrombosis prevention, especially relevant for COVID-19-related…
Targeting Platelet Enzyme to Prevent Dangerous Blood Clots Safely
Associate Professor Justin Hamilton and colleagues have published a paper in Science Translational Medicine on how platelets about to form pathogenic clots such as those in stroke and heart attack can be specifically…
RT @lab_hamilton: Aaaaaaaaand it's finally out! Check out our latest publication in Science Translational Medicine - out today!
Disrupting the platelet internal membrane via PI3KC2α inhibition impairs thrombosis independently of canonical platelet activation https://t.co/LxNm2lqN9W
RT @lab_hamilton: Aaaaaaaaand it's finally out! Check out our latest publication in Science Translational Medicine - out today!
RT @lab_hamilton: Aaaaaaaaand it's finally out! Check out our latest publication in Science Translational Medicine - out today!
RT @lab_hamilton: Aaaaaaaaand it's finally out! Check out our latest publication in Science Translational Medicine - out today!
RT @rtjunejo: Disrupting the platelet internal membrane via PI3KC2α inhibition impairs thrombosis independently of canonical platelet activ…
RT @lab_hamilton: Aaaaaaaaand it's finally out! Check out our latest publication in Science Translational Medicine - out today!
RT @lab_hamilton: Aaaaaaaaand it's finally out! Check out our latest publication in Science Translational Medicine - out today!
RT @rtjunejo: Disrupting the platelet internal membrane via PI3KC2α inhibition impairs thrombosis independently of canonical platelet activ…
RT @Hragy: Breaking!!! Super duper important! Read please if you are a CV specialist : Disrupting the platelet internal membrane via PI3K…
Disrupting the platelet internal membrane via PI3KC2α inhibition impairs thrombosis independently of canonical platelet activation https://t.co/uuEE6UXDBq
Breaking!!! Super duper important! Read please if you are a CV specialist : Disrupting the platelet internal membrane via PI3KC2α inhibition impairs thrombosis independently of canonical platelet activation | Science Translational Medicine https://t.co/6NAUCHBXjn
RT @lab_hamilton: Aaaaaaaaand it's finally out! Check out our latest publication in Science Translational Medicine - out today!
RT @lab_hamilton: Aaaaaaaaand it's finally out! Check out our latest publication in Science Translational Medicine - out today!
Really cool work from Justin @lab_hamilton!! Disrupting the platelet internal membrane via PI3KC2α inhibition impairs thrombosis independently of canonical platelet activation | Science Translational Medicine https://t.co/2oGaLyGugX
RT @lab_hamilton: Aaaaaaaaand it's finally out! Check out our latest publication in Science Translational Medicine - out today!
RT @lab_hamilton: Aaaaaaaaand it's finally out! Check out our latest publication in Science Translational Medicine - out today!
RT @lab_hamilton: Aaaaaaaaand it's finally out! Check out our latest publication in Science Translational Medicine - out today!
RT @lab_hamilton: Aaaaaaaaand it's finally out! Check out our latest publication in Science Translational Medicine - out today!
RT @lab_hamilton: Aaaaaaaaand it's finally out! Check out our latest publication in Science Translational Medicine - out today!
RT @lab_hamilton: Aaaaaaaaand it's finally out! Check out our latest publication in Science Translational Medicine - out today!
@lab_hamilton @MonashUni research in @ScienceTM proposes novel compound to prevent pathogenic blood clots but not interfere w normal clotting, unlike current #Heart_attack & #stroke medications DOI:10.1126/scitranslmed.aar8430. A/Prof Hamilton explains: https://t.co/dGbYQdyTmQ https://t.co/avgTPTQ7Ra
Disrupting the platelet internal membrane via PI3KC2α inhibition impairs thrombosis independently of canonical platelet activation https://t.co/6gQqPZofCw
Aaaaaaaaand it's finally out! Check out our latest publication in Science Translational Medicine - out today!
Pretty interesting novel target for anti-platelet therapy that reduces spon bleeding risk. Disrupting the platelet internal membrane via PI3KC2α inhibition impairs thrombosis independently of canonical platelet activation https://t.co/C4bMCjWkzm